• English
  • Français
Bladder Cancer CanadaBladder Cancer CanadaBladder Cancer CanadaBladder Cancer Canada
  • Bladder Cancer
    • See Red?
    • What is Bladder Cancer?
    • Statistics and Risk Factors
    • Symptoms and Diagnosis
    • Staging and Grading
    • Types of Bladder Cancer
      • Non-Muscle Invasive Bladder Cancer
      • Muscle Invasive Bladder Cancer
      • Metastatic Bladder Cancer
      • Upper Tract Urothelial Carcinoma
    • Treatment Options
      • TURBT
      • BCG
      • Chemotherapy and Radiation
      • Bladder Removal
      • Immunotherapy
      • Bladder Preservation Options
      • Palliative Care
      • Clinical Trials
      • Advanced Bladder Cancer Treatment
    • Research and Studies
  • Patients
    • Get Support
      • Support Groups
      • One2One Peer Support
      • Online Discussion Forum
      • Contact Us by Phone or Email
    • Navigating Your Diagnosis
      • Newly Diagnosed?
      • Coping With Emotions
      • Health and Wellness Resources
      • Clinical Trials
    • Educational Resources
      • Guidebooks
      • Webinars and Videos
      • Podcast
      • Newsletter
      • Glossary
    • Upcoming Events
    • News and Stories
    • Links and Other Resources
  • Get Involved
    • Donate
    • Fundraise
    • Volunteer
    • Share Your Story
    • Patient Study Recruitment
    • Patient Self-Advocacy
    • Bladder Cancer Awareness Month
    • Your Impact
  • Health Care Practitioners
    • Doctor Resources
    • BCC Research Grant Applications
    • BCC Research Grant Recipients
    • CBCIS
    • CBCRN
    • Medical Advisory Board
  • About Us
    • Who We Are
    • Board of Directors
    • Staff
    • Medical Advisory Board
    • Sponsors and Partners
    • Financial Statements and Annual Reports
    • Newsletter
    • Contact Us
  • Walk With Us
  • Donate

Dr. Girish Kulkarni
(MD, PhD, FRCSC)

Vice Chair
Medical Advisory Board
University of Toronto,
Toronto, ON
Dr. Kulkarni completed his medical school and residency in urology at the University of Toronto. During his residency, he entered the Surgeon Scientist Training Program and completed his PhD in clinical epidemiology through the Institute of Health Policy, Management and Evaluation. He then completed a fellowship in urologic oncology at the Memorial Sloan-Kettering Cancer Center in New York City. Dr. Girish Kulkarni joined the uro-oncology faculty in 2011 and is a urologic surgeon in the Department of Surgical Oncology at the Princess Margaret Cancer Centre, University Health Network. He is also a surgeon-scientist who is affiliated with the Department of Surgery, Faculty of Medicine at the University of Toronto. At the University of Toronto, he is an associate professor in the Department of Surgery, as well as at the Institute of Health Policy, Management and Education. He also holds a senior adjunct scientist position at the Institute for Clinical Evaluative Sciences. Dr. Kulkarni’s main clinical interests are in bladder and prostate cancer. He is also highly involved in the management of “orphan” genitourinary malignancies including urothelial carcinoma of the upper tract and penile carcinoma. Dr. Kulkarni’s primary research interests revolve around the epidemiology of genitourinary malignancies, particularly bladder cancer. His investigations are dedicated towards the understanding of population-level quality of care of urologic malignancies, quality of life and the health economics associated with urologic malignancies. He is also actively involved in clinical trials and is the site principal investigator for numerous non-muscle invasive and muscle invasive bladder cancer trials at the Princess Margaret Cancer Centre. He is an active member of Bladder Cancer Canada and serves on its medical advisory board. Examples of his innovative work in bladder cancer include the development and validation of the Bladder Utility Symptom Scale (BUSS), which is a health related quality of life tool that helps clinicians rapidly measure quality of life in all bladder cancer patients and which will help policy makers determine the cost-effectiveness of bladder cancer treatments. This instrument is being adopted into clinical practice worldwide. He has also promoted the use of bladder-sparing trimodal therapy for patients with muscle invasive bladder cancer and is an established member of the University Health Network’s Multidisciplinary Bladder Cancer Clinic. His work in bladder cancer has been presented at multiple national and international meetings and is currently funded by the Canadian Institutes for Health Research.

Bladder Cancer Canada

4936 Yonge Street, Suite 1000, Toronto, ON M2N 6S3
Phone: 1-866-674-8889
Email & Media Contact: info@bladdercancercanada.org

Privacy Policy | Donor Bill of Rights

Charitable Reg No. 83612 6060 RR0001

© Bladder Cancer Canada.

SUBSCRIBE TO OUR NEWSLETTER
SEND US A MESSAGE
  • Bladder Cancer
    • See Red?
    • What is Bladder Cancer?
    • Statistics and Risk Factors
    • Symptoms and Diagnosis
    • Staging and Grading
    • Types of Bladder Cancer
      • Non-Muscle Invasive Bladder Cancer
      • Muscle Invasive Bladder Cancer
      • Metastatic Bladder Cancer
      • Upper Tract Urothelial Carcinoma
    • Treatment Options
      • TURBT
      • BCG
      • Chemotherapy and Radiation
      • Bladder Removal
      • Immunotherapy
      • Bladder Preservation Options
      • Palliative Care
      • Clinical Trials
      • Advanced Bladder Cancer Treatment
    • Research and Studies
  • Patients
    • Get Support
      • Support Groups
      • One2One Peer Support
      • Online Discussion Forum
      • Contact Us by Phone or Email
    • Navigating Your Diagnosis
      • Newly Diagnosed?
      • Coping With Emotions
      • Health and Wellness Resources
      • Clinical Trials
    • Educational Resources
      • Guidebooks
      • Webinars and Videos
      • Podcast
      • Newsletter
      • Glossary
    • Upcoming Events
    • News and Stories
    • Links and Other Resources
  • Get Involved
    • Donate
    • Fundraise
    • Volunteer
    • Share Your Story
    • Patient Study Recruitment
    • Patient Self-Advocacy
    • Bladder Cancer Awareness Month
    • Your Impact
  • Health Care Practitioners
    • Doctor Resources
    • BCC Research Grant Applications
    • BCC Research Grant Recipients
    • CBCIS
    • CBCRN
    • Medical Advisory Board
  • About Us
    • Who We Are
    • Board of Directors
    • Staff
    • Medical Advisory Board
    • Sponsors and Partners
    • Financial Statements and Annual Reports
    • Newsletter
    • Contact Us
  • Walk With Us
  • Donate
Bladder Cancer Canada